Journal of Clinical & Translational Endocrinology (Jun 2019)

Serum free thiols in type 2 diabetes mellitus: A prospective study

  • Emmelien E.M. Schillern,
  • Andreas Pasch,
  • Martin Feelisch,
  • Femke Waanders,
  • Steven H. Hendriks,
  • Rik Mencke,
  • Geert Harms,
  • Klaas H. Groenier,
  • Henk J.G. Bilo,
  • Jan-Luuk Hillebrands,
  • Harry van Goor,
  • Peter R. van Dijk

Journal volume & issue
Vol. 16

Abstract

Read online

Aims: Oxidative stress is a driver in the development of type 2 diabetes (T2DM) complications. As thiols (R-SH) are oxidized by reactive oxygen and sulfur species, circulating concentrations may directly reflect systemic redox status. We hypothesized that high serum R-SH concentrations are a reflection of a favourable redox status and may therefore positively associate with disease status. Methods: R-SH were measured in serum of 943 T2DM outpatients (55% males, 65 years and HbA1c of 6.7% (50 mmol/mol)) with a follow-up period of 1.2 years. Results: In the highest R-SH tertile patients were younger, more often men, had less microvascular complications, lower HbA1c and were more often treated nutritionally or with oral glucose-lowering drugs. Age- and sex adjusted hazard ratios for developing micro-, macro- or any complication plus death were 0.994, 0.992 and 0.993: even after adjustment for potential confounders. The Harrell’s C statistic to predict microvascular complications or any complication plus death was higher in the models with R-SH than in those without R-SH. Conclusions: Although R-SH concentrations were associated with a favourable disease status, it did not add to the predictive capacity for long-term complications. Based on the current data R-SH seems unsuitable as a prognostic marker in T2DM. Keywords: Type 2 diabetes, Glycemia, Oxidative stress, Thiols, Free sulfhydryl